SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (4996)1/25/1998 6:52:00 PM
From: Bradpalm1  Read Replies (2) of 23519
 
<<Braddy, I suppose I have to spell it out for you again:>>

On the contrary, Tunica, let me spell it out for YOU again. Oral dipyridamole (Persantine) may be a worthless medication but at least it's benign and well tolerated. Intravenous dipyridamole, which is commonly used for cardiac stress testing, is also well-tolerated despite the fact that it's administered to known cardiac patients and is used in much higher serum concentrations.

Therefore, to belabor this point, dipyridamole, another Type V-PDE inhibitor like sildenafil, appears to be safe and well-tolerated even in patients with cardiac disease and multiple cardiac risk factors. Therefore sildenafil should be safe and well-tolerated as well. And unless Pfizer plans on releasing an intravenous formulation of sildenafil, I think you don't need to worry about the need for cardiac moniters in the bedroom.

<<. Braddy is not eligilble to sit for this essay question because he is too distracted worrying about Sildenafil.>>

Tunica, you're the one who's worried about sildenafil. I'm just trying to moniter and correct your misinformation.

Bradpalm1

P.S. once again, 'Amiodarone' is not a PDE inhibitor
P.P.S. GO BRONCOS!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext